
Preeclampsia (PE) affects around 2–5% of pregnant women. It is a major cause of maternal and perinatal morbidity and mortality. In an attempt to prevent preeclampsia, many strategies based on antenatal care, change in lifestyle, nutritional supplementation, and drugs have been studied. The aim of this paper is to review recent evidence about primary and secondary prevention of preeclampsia.
Review Article, 613, Antioxidants, 618, Pre-Eclampsia, Pregnancy, Secondary Prevention, Humans, Nitric Oxide Donors, Diuretics, Progesterone, Prenatal Care, Gynecology and obstetrics, Diet, Sodium-Restricted, Exercise Therapy, Primary Prevention, Dietary Supplements, RG1-991, Calcium, Female, Progestins, Bed Rest, Platelet Aggregation Inhibitors
Review Article, 613, Antioxidants, 618, Pre-Eclampsia, Pregnancy, Secondary Prevention, Humans, Nitric Oxide Donors, Diuretics, Progesterone, Prenatal Care, Gynecology and obstetrics, Diet, Sodium-Restricted, Exercise Therapy, Primary Prevention, Dietary Supplements, RG1-991, Calcium, Female, Progestins, Bed Rest, Platelet Aggregation Inhibitors
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 26 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
